# Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes

> **NCT02846831** · PHASE2 · COMPLETED · sponsor: **Institut de Recherches Cliniques de Montreal** · enrollment: 36 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **OTHER:** 12-day intervention with sensor-augmented pump therapy
- **OTHER:** 12-day intervention with single-hormone closed-loop strategy
- **DEVICE:** Insulin pump
- **DEVICE:** Continuous glucose monitoring system
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT02846831
- **Lead sponsor:** Institut de Recherches Cliniques de Montreal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-24
- **Primary completion:** 2020-01-27
- **Final completion:** 2020-01-27
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02846831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02846831, "Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02846831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*